RLYB — Rallybio Cashflow Statement
0.000.00%
Last trade - 00:00- $44.64m
- -$10.09m
- $0.86m
Annual cashflow statement for Rallybio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -47 | -66.7 | -74.6 | -57.8 | -8.98 |
| Depreciation | |||||
| Non-Cash Items | 5.15 | 10.1 | 9.87 | 8.62 | -16.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.78 | -0.936 | 4.28 | -0.258 | -4.19 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -45.5 | -57.3 | -60.3 | -49.3 | -29.8 |
| Capital Expenditures | -0.333 | -0.054 | -0.012 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2 | -112 | 27.7 | 33.5 | 47.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.33 | -112 | 27.7 | 33.5 | 47.3 |
| Financing Cash Flow Items | -3.23 | -0.693 | -0.139 | -0.268 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 83 | 51.1 | 0.143 | 5.2 | 0.016 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 35.1 | -118 | -32.5 | -10.6 | 17.5 |